The gift includes $3 million for six cancer research projects to be spearheaded by co-investigators from both NYU Langone and Technion, and $6 million to establish a state-of-the-art research facility on Technion's Haifa campus in support of these and other projects focused on the emerging field of cancer metabolomics.
Laura Perlmutter has been on NYU Langone's board of trustees since 1985 and has served on its cancer advisory board since 2005, while Isaac Perlmutter, chairman of Marvel Entertainment, recently was named to the board. The couple previously contributed more than $58 million in support of NYU Langone, including $50 million in January 2014 to advance cancer research and treatment at the medical center.
"NYU Langone and the Technion have a shared, longstanding commitment to advancing cancer research," said Dafna Bar-Sagi, senior vice president and vice dean for science at NYU Langone, who helped establish the NYU Langone-Technion partnership. "We are now at a great moment in our institutions' illustrious histories, a point from which we can jointly leverage the talent and creativity of our researchers toward accelerating breakthroughs. The foresight and the generosity of the Perlmutters, particularly at this time of financial challenge in funding for basic research, will have tremendous impact."